Yahoo Web Search

    • Bayer to pay up to $4 billion for Asklepios Bio

      Market Watch· 3 days ago

      The German company's biggest pharmaceutical acquisition since its purchase of domestic rival Schering AG in 2006 is also an attempt to tackle one of a series of challenges that has been plaguing ...